HOUSE MARK PHARMACEUTICAL

Brand Owner (click to sort) Address Description
ATARA Atara Biotherapeutics, Inc. 611 Gateway Blvd, Suite 900 South San Francisco CA 94080 House mark for pharmaceutical and therapeutic preparations for the treatment of patients with chronic diseases, namely, cancer, kidney disease, diabetics, cachexia, age related sarcopenia, and protein-energy wasting, none of the foregoing to be used for pharmaceutical preparations for treatment of rheumatoid arthritis and psoriasis;
ATARA Atara Biotherapeutics, Inc. 611 Gateway Blvd, Suite 900 South San Francisco CA 94080 house mark for pharmaceutical and therapeutic preparations for the treatment of patients with chronic diseases, namely, cancer, kidney disease, diabetics, cachexia, age related sarcopenia, and protein-energy wasting, none of the foregoing to be used for pharmaceutical preparations for treatment of rheumatoid arthritis and psoriasis;
AXOVANT Axovant Sciences GmbH Viaduktstrasse 8 Basel 4051 Switzerland House mark for pharmaceutical and biological preparations used in the treatment of central nervous system and other neurological disorders, diseases and conditions;
AXOVANT Axovant Sciences Ltd Clarendon House, PO Box HM 1022 Hamilton HM DX Hamilton Bermuda House mark for pharmaceutical and biological preparations used in the treatment of central nervous system and other neurological disorders, diseases and conditions;
COLBAR COLBAR R&D LTD. 86 Sokolov Street Ramat Hasharon, 47232 Israel HOUSE MARK FOR PHARMACEUTICAL AND SANITARY PREPARATIONS NAMELY, PHARMACEUTICAL PREPARATIONS COMPRISED OF COLLAGEN;COL BAR;HOUSE MARK FOR MEDICAL SERVICES; DENTAL SERVICES IN CONNECTION WITH COLLAGEN BASED PRODUCTS; COSMETIC BODY AND SKIN; CARE SERVICES IN CONNECTION WITH COLLAGEN BASED PRODUCTS;HOUSE MARK FOR SURGICAL, MEDICAL, DENTAL AND VETERINARY APPARATUS AND INSTRUMENTS NAMELY, COMPRISED OF COLLAGEN;
CONNETICS STIEFEL LABORATORIES, INC. 251 Little Falls Drive Wilmington DE 19808 house mark for pharmaceutical and biopharmaceutical preparations for the prevention and/or treatment of diseases; reagents, preparations and test kits for clinical, laboratory, medical and diagnostic uses;
DEMENTIA SOLUTIONS Axovant Sciences GmbH Viaduktstrasse 8 Basel 4051 Switzerland House mark for pharmaceutical and biological preparations used in the treatment of central nervous system and other neurological disorders, diseases and conditions;
EMD LEXIGEN MERCK KGAA Frankfurter Str. 250 64293 Darmstadt F128/002 Germany House mark for pharmaceutical and biopharmaceutical products for the treatment of cancer, MDS, genetic disorders and immunological disorders; novel protein drugs for use in the area of oncology, immune therapies and for the treatment of metabolic disorders;House mark for scientific research and development in the area of pharmacy, medicine, biology and genetics, developing treatments for serious and life-threatening diseases as well as broad technology platforms that will lead to new therapies;
FOGPHARMA Fog Pharmaceuticals, Inc. 30 Acorn Park Drive Cambridge MA 02140 House mark for pharmaceutical and medical preparations containing biomedical compounds, namely, amino acids, peptides, stapled peptides, and synthetic peptides, all comprised of amino acids for the medical treatment of cancer, inflammatory conditions, immunological disorders, cardiovascular conditions, infectious diseases, and neurological conditions; biomedical compounds for medical purposes, namely, miniproteins and cell-penetrating miniproteins (CPMPs) arrays for diagnosing cancer, inflammatory conditions, immunological disorders, cardiovascular conditions, infectious diseases, and neurological conditions;FOG PHARMA;Biomedical compounds, namely, amino acids; biomedical compounds, namely, peptides, stapled peptides, and synthetic peptides, all comprised of amino acids, for use in scientific and laboratory research; biomedical compounds, namely, miniproteins, and cell-penetrating miniproteins (CPMPs) in raw material form for use in scientific and laboratory research;
GLENMARK Glenmark Pharmaceuticals Inc., USA 750 Corporate Dr. Mahwah NJ 07430 House mark for pharmaceutical and chemical preparations;GLEN MARK;
KYMERA THERAPEUTICS Kymera Therapeutics, Inc. 200 Arsenal Yards Blvd., Suite 230 Watertown MA 02472 House mark for pharmaceutical and medical preparations for the treatment of oncology, autoimmune, immune-oncology and other related diseases; House mark for pharmaceutical and medical therapeutics for the treatment of oncology, autoimmune, immune-oncology and other related diseases; House mark for diagnostic reagents for the treatment of oncology, autoimmune, immune-oncology and other related diseases;THERAPEUTICS;Research and development of therapeutic drugs for the treatment of oncology, autoimmune, immune-oncology and other related diseases; Research and development of therapeutic antibodies and pharmaceuticals, and research and development of technology in the field of therapeutic antibodies, pharmaceuticals and biopharmaceuticals; Development of pharmaceutical preparations and medicines; Drug development and discovery; Medical research for development of therapeutic modalities for treatment of diseases; Assays and reagents for use in scientific and biomedical research; Clinical studies; Preclinical and clinical development of therapeutic products;
S SENTRACHEM LIMITED 20 ANDERSON STREET JOHANNESBURG South Africa house mark for pharmaceutical, veterinary and sanitary substances; infant's and invalids' foods; plasters, material for bandaging; material for stopping teeth, dental wax; disinfectants; preparations for killing weeds and destroying vermin;SENTRACHEM LIMITED;house mark for chemical products used in industry, science, photography, agriculture, horticulture, forestry; artificial and synthetic resins, plastics in the form of powders, liquids or pastes, for industrial use; manures (natural and artificial); fire extinguishing compositions; tempering substances and chemical preparations for soldering; chemical substances for preserving foodstuffs; tanning substances; adhesive substances used;
THE DEMENTIA SOLUTIONS COMPANY Axovant Sciences GmbH Viaduktstrasse 8 Basel 4051 Switzerland House mark for pharmaceutical and biological preparations used in the treatment of central nervous system and other neurological disorders, diseases and conditions;
 

Where the owner name is not linked, that owner no longer owns the brand

    
Technical Examples
  1. The invention enables a recorder to mark a recording as an event is being recorded. The invention can enable the specification of a mark so that the mark is associated with recording data obtained at a time other than the time at which the mark is specified ("non-contemporaneous marking"), i.e., prior to the time of the mark ("retrospective marking") or after the time of the mark ("predictive marking"). The invention can also enable the use of multiple types of marks, each type of mark having a particular meaning. Additionally, the invention can enable marking capability to be implemented so that specification of a mark causes predetermined operation of the recording unit in accordance with the type of the mark ("augmented marking").